School of Chemistry, MOE Key Laboratory for Non-equilibrium Synthesis and Modulation of Condensed Matter, Xi'an Key Laboratory of Sustainable Energy Material Chemistry, Xi'an Jiaotong University, Xi'an, 710049, PR China.
School of Chemistry, MOE Key Laboratory for Non-equilibrium Synthesis and Modulation of Condensed Matter, Xi'an Key Laboratory of Sustainable Energy Material Chemistry, Xi'an Jiaotong University, Xi'an, 710049, PR China.
Colloids Surf B Biointerfaces. 2021 Aug;204:111790. doi: 10.1016/j.colsurfb.2021.111790. Epub 2021 Apr 26.
In past decades, to improve the chemotherapeutic efficiency and reduce the systemic toxicity of small molecule anti-cancer drugs, polymer-based drug delivery systems (DDSs) have attracted great attention for tumor treatment due to their remarkable biocompatibility and responsive degradation in tumor microenvironment (TME). Herein, we developed a kind of pH-responsive and degradable hyperbranched polymeric nanocarriers via yne-phenol click-reaction of resveratrol (RSV) with bifunctional n-butyl dipropiolate (BDP) for efficient doxorubicin (DOX) delivery. The natural product RSV with three phenol groups has excellent antioxidant activity and synergetic enhancement for some anticancer drugs such as DOX. RSV tends to attack the alkynyl groups on BDP by nucleophilic addition in the presence of base as catalyst to afford hyperbranched polyprodrug (denoted as RB). PEGylated RB (termed as RBP) were further synthesized to improve the water solubility and prolong blood circulation by the click reaction of propiolate-terminated RB with amino terminated poly(ethylene glycol) (PEG-NH). Interestingly, the RBP have high DOX loading ratio (∼58.6 %) at neutral pH, but the vinyl-ether bonds in RB could break down at low pH conditions such as acidic TME (extracellular pH∼6.8, endosomes and lysosomes pH∼5.0) that leading to the targeting release of DOX and RSV. Therefore, the developed RBP@DOX nanoparticles exhibited high kill efficiency to tumor cells and slight damage to normal cells due to the effective delivery and release of DOX and RSV in tumor sites and the synergistic enhancement effect of two drugs.
在过去的几十年中,为了提高小分子抗癌药物的化疗效率并降低其全身毒性,基于聚合物的药物输送系统(DDS)由于其在肿瘤微环境(TME)中的出色生物相容性和响应性降解而受到极大关注,可用于肿瘤治疗。在此,我们通过白藜芦醇(RSV)与双官能团正丁基丙二酸盐(BDP)的炔-酚点击反应开发了一种 pH 响应和可降解的超支化聚合物纳米载体,用于高效阿霉素(DOX)输送。具有三个酚基的天然产物 RSV 具有出色的抗氧化活性,并可与某些抗癌药物(如 DOX)协同增强作用。RSV 在存在碱作为催化剂的情况下,通过亲核加成倾向于攻击 BDP 上的炔基,以提供超支化的多前药(表示为 RB)。进一步通过炔丙基封端的 RB 与氨基封端的聚(乙二醇)(PEG-NH)的点击反应合成了聚乙二醇化 RB(称为 RBP),以提高水溶性并延长血液循环时间。有趣的是,RBP 在中性 pH 下具有高 DOX 载药率(约 58.6%),但 RB 中的乙烯醚键在低 pH 条件下(例如酸性 TME(细胞外 pH 约 6.8,内涵体和溶酶体 pH 约 5.0))会断裂,导致 DOX 和 RSV 的靶向释放。因此,开发的 RBP@DOX 纳米颗粒由于在肿瘤部位有效输送和释放 DOX 和 RSV 以及两种药物的协同增强作用,对肿瘤细胞具有高杀伤效率,对正常细胞的损伤较小。